An International, Multicentre, Randomised, Open-label, No-treatment Controlled, Parallel-group, Dose-response Study to Investigate the Effect of Once Daily Nitisinone on 24-hour Urinary Homogentisic Acid Excretion in Patients With Alkaptonuria After 4 Weeks Treatment.
Phase of Trial: Phase II
Latest Information Update: 04 Dec 2014
Price : $35 *
At a glance
- Drugs Nitisinone (Primary)
- Indications Alkaptonuria
- Focus Adverse reactions; Therapeutic Use
- Acronyms SONIA1
- 10 Jun 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 14 Apr 2014 New trial record